/stocks — the workspaceLOADING
All GRMLW SEC filings, by type → · Earnings date & implied move · Search inside filings
GRMLW is not among the 142 companies we ingest every day, so it is not in the fundamentals screener or the size and group lists built from it. This page reads its SEC filings when the page is built. Ask us to add it: we keep a count per ticker and nothing about you.
Latest report (10-Q, filed 2026-08-17). Three months to 2026-06-30 against 2025-06-30: Net loss $3.7M, 10.0% smaller than $4.1M. Six months to 2026-06-30 against 2025-06-30: Operating cash used $11.8M, 238.7% larger than $3.5M. Read it line by line, each linked to its source → · Every report →
Greenland Mines Ltd (GRMLW) is a biological products, (no diagnostic substances) company. 2 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
Every filed figure on this page is free to read, dated and sourced; no column is held back for a paid plan. Each section with figures says what date they are true as of and where they come from.
What’s behind GRMLW’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has GRMLW been issuing shares? Offering history →
Volume against its own history: 69% of its last 134 sessions were lighter than the last one, the 2026-11-09 session. End-of-day bars (Databento). Volume detail
| Diluted EPS | That year | Year before, same report | Change | Report |
|---|---|---|---|---|
| fiscal 2025 | -0.22 USD | -0.32 USD | not a growth rate (a year at or below zero) | 10-K filed 2026-04-01 |
| fiscal 2024 | -0.32 USD | -0.05 USD | not a growth rate (a year at or below zero) | 10-K filed 2025-03-31 |
Concepts read: us-gaap:EarningsPerShareDiluted
Per filed share, as each report states it. Free cash flow per share is operating cash flow less capital expenditure, over the diluted weighted average share count (or net income over diluted EPS where the count is tagged per share class).
Each year’s change comes from one annual report, which states that year and the year before on the same share basis, and the rate compounds those changes; so a split or a restatement between reports cannot bend it. A rate needs a positive figure at both ends of its window. The DCF above grows total free cash flow and divides by today’s share count, so a per-share rate also carries the buybacks or new shares of those years. These are past figures, not a forecast.
Not shown yet: the P/E range GRMLW has traded at, which would set the discount rate and terminal assumptions against its own history. It needs a long daily price history we are not yet licensed to display.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from GRMLW’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as GRMLW tagged it: net income us-gaap:NetIncomeLoss, EPS us-gaap:EarningsPerShareDiluted, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
A plain-English read on GRMLW plus an auto-SWOT, built from GRMLW's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts, a bull, a bear, a risk manager, and a PM, debate GRMLW using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Ask about GRMLW’s revenue, earnings, valuation, filings, insiders or Congress trades. Answers come only from the numbered evidence the research brief uses, each citing the items it rests on. A question about one figure is answered by code, free. One that puts figures together is 1 generation (Pro). A question about whether to buy, sell or hold, how much, or where the price goes gets a refusal.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Closes only, split-adjusted. Range of the 135 sessions on file, under a full year. An average needs that many sessions on file to print. These are measurements, not support, resistance or targets. Chart with studies
Withheld: 200-session average (needs 200 sessions; 135 are on file).
Daily closes from 2026-04-28 through 2026-11-09, 135 sessions, split-adjusted (1 split applied), history before 2026-04-28 left out at a corporate action. No direction, pattern, entry, target or overbought label: these are measurements. Filings dated on the move days are in GRMLW’s filings; the chart with studies draws every figure.
Written by code from 135 end-of-day bars through 2026-11-09. Written by code from the data on file, not by a model. Information, not investment advice: it describes the security and recommends nothing to anyone.
Projected from GRMLW's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentGRMLW files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
On file for GRMLW from Nov 10, 2026 to Nov 23, 2026: filing deadline (below).
| Event | Result |
|---|---|
| Earnings date | nothing in the window. No date in the window: no regular report cadence in the filings. |
| Filing deadline | on file. In the window: the 10-Q for the quarter ending Sep 30, 2026, due 40 to 45 days after it as SEC states no filer status for it, the span covers every status, falls due between Nov 9, 2026 and Nov 16, 2026. A notice of late filing (NT 10-Q) was filed Aug 14, 2026. Newest periodic report on file: the 10-Q for the period ending Jun 30, 2026, filed Aug 17, 2026. filing list on EDGAR |
| Ex-dividend date | not covered. Not checked. This attestation does not cover ex-dividend dates. |
This records what these sources returned when they were read. It is not a forecast: a company can announce an event at any time, and ex-dividend dates are not covered. Window 2026-11-10 to 2026-11-23, Eastern dates. Deadlines follow SEC Rules 13a-1 and 13a-13 and Form 20-F, moved past weekends and federal holidays by Rule 0-3.
1 of the 1 checks that ran found nothing new for GRMLW. 3 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
None of the 5 estimators could run on GRMLW's filings.
One estimator is a point estimate, not a range, so no band and no valuation label are published for GRMLW. Below is everything that was checked, so the refusal can be read rather than taken on trust.
Nothing produced a value.
No fiscal year of price history was on record; the historical multiples need 5. No sector peer set is priced for GRMLW, so sector medians could not fill the gaps.
Every refusal recorded for GRMLW → · How often we decline, and why →
Only 1 of 5 tests could be computed from the filings — too few to summarise, so the individual results are shown without an overall label.
The score is passed over computable, not passed out of five. If only three tests could be run on GRMLW’s filings, the score is out of three and the other two are listed with the reason they were skipped. Scoring a skipped test as a failure would punish a company for how its industry reports, and scoring it as a pass would flatter one.
Labels come from that ratio:
Below three computable tests we publish no label at all and show the individual results instead. A summary drawn from one or two tests is not a summary.
Free cash flow coverage carries the most weight in practice, because dividends are paid in cash and free cash flow is the cash actually available to pay them. The earnings payout ratio is the better-known test but the weaker one — earnings are an accounting figure, dividends are not. Where the two disagree, believe the cash.
Why tests get skipped. A REIT gets no earnings payout ratio: GAAP depreciation on appreciating property understates a REIT’s distributable earnings, which is exactly why the industry reports FFO and why REITs are required to distribute most of their taxable income. Banks and insurers get no leverage test, because deposits are debt and structurally high leverage is what a balance-sheet business is, not a warning sign.
The biggest limitation, stated plainly. The coverage tests read a single fiscal year, and one year of cash flow is far more volatile than a dividend record. A legal settlement, a tax payment or an acquisition can sink coverage in a year that says nothing about the dividend. Where a weak year contradicts a long unbroken record, we say so above rather than letting the harsher number stand alone — but you should still check what happened in that specific year.
The streak is the weakest test here, and it is deliberately listed last. Every dividend that was ever cut had an unbroken streak right up until the year it was cut. A freeze does not break the run — a company that holds its dividend flat through a bad year has not cut it — so raises are counted separately, and a long flat run cannot pass itself off as dividend growth.
Every figure above is from GRMLW’s own SEC filings and the arithmetic is stated on this page. This describes what the filings show about the dividend’s coverage — it is not a prediction that the dividend will or will not be cut, not a recommendation, and not investment advice. A covered dividend can still be cut, and a strained one can still be maintained for years. Educational information only.
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.
Group: Biological Products, (No Diagnostic Substances), the SEC industry code GRMLW files under. 4 companies in our stored table file under it.
| Metric | GRMLW | Group median | 25th to 75th percentile | Where GRMLW sits |
|---|---|---|---|---|
| Net marginnet income divided by revenue, same fiscal year | Withheld: 4 companies in this SIC group have the figure on file, and a group prints from 6. | |||
| Free cash flow marginoperating cash flow less capital expenditure, divided by revenue, same fiscal year | Withheld: 4 companies in this SIC group have the figure on file, and a group prints from 6. | |||
| Return on equitynet income divided by stockholders’ equity at the fiscal year end | Withheld: 4 companies in this SIC group have the figure on file, and a group prints from 6. | |||
One filed metric per row, each a ratio of two figures from the same annual report; no composite and no grade. Percentile is the share of the group’s other companies with a lower figure. A group prints from 6 companies with the figure. The group is drawn from our stored table (the S&P 500 issuers and the companies we cover, each with its newest annual report read), not from every filer in the class. Industry pages show the same medians by group.
Head office: Charlotte, North Carolina, United States · the company’s charter and its head office are in different states.
Source: the cover page of Greenland Mines Ltd’s 10-Q filed 2026-08-17, on EDGAR. Filings checked 2026-11-10. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
No tracked institution reported a position in GRMLW in the latest 13F round.
Of 2 sales in the last ~6 months, 0 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 2 were filed without it.
| El-Dada Riad HusseinInsider | SELL | $33K | view → |
| LeBlanc JeffChief Financial Officer | BUY | $136K | view → |
| Sawyer Jason DavidDirector | BUY | $56K | view → |
| McGarity JonDirector | BUY | $25K | view → |
| LeBlanc JeffChief Financial Officer | BUY | $245K | view → |
| El-Dada Riad HusseinDirector | SELL | $41K | view → |
No lawmaker has disclosed a trade in GRMLW under the STOCK Act.